NO20054020L - Medicine for the prevention and treatment of arteriosclerosis and hypertension - Google Patents
Medicine for the prevention and treatment of arteriosclerosis and hypertensionInfo
- Publication number
- NO20054020L NO20054020L NO20054020A NO20054020A NO20054020L NO 20054020 L NO20054020 L NO 20054020L NO 20054020 A NO20054020 A NO 20054020A NO 20054020 A NO20054020 A NO 20054020A NO 20054020 L NO20054020 L NO 20054020L
- Authority
- NO
- Norway
- Prior art keywords
- arteriosclerosis
- hypertension
- medicine
- prevention
- treatment
- Prior art date
Links
- 206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
- 206010020772 Hypertension Diseases 0.000 title abstract 2
- 208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 abstract 1
- ZKFQEACEUNWPMT-UHFFFAOYSA-N Azelnidipine Chemical compound CC(C)OC(=O)C1=C(C)NC(N)=C(C(=O)OC2CN(C2)C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZKFQEACEUNWPMT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002051 C09CA08 - Olmesartan medoxomil Substances 0.000 abstract 1
- 229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
- UQGKUQLKSCSZGY-UHFFFAOYSA-N Olmesartan medoxomil Chemical compound C=1C=C(C=2C(=CC=CC=2)C2=NNN=N2)C=CC=1CN1C(CCC)=NC(C(C)(C)O)=C1C(=O)OCC=1OC(=O)OC=1C UQGKUQLKSCSZGY-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 abstract 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 abstract 1
- 229950004646 azelnidipine Drugs 0.000 abstract 1
- 239000000480 calcium channel blocker Substances 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 229960001199 olmesartan medoxomil Drugs 0.000 abstract 1
Abstract
En medisin for forhindring og/eller behandling av arteriosklerose, hypertensjon, hjertesykdommer, nyresykdommer eller cerebrovaskulære sykdommer. Det omfatter følgende bestanddeler som aktive bestanddeler: (A) en angiotensin II reseptorantagonist valgt fra gruppen bestående av en forbindelse representert ved følgende formel (I), farmakologisk akseptable estere derav og farmakologisk akseptable salter av disse (for eksempel olmesartanmedoksomil); og (B) en kalsiumantagonist valgt fra gruppen bestående av 1,4-dihydropyridinforbindelser og farmakologisk akseptable salter av disse (for eksempel azelnidipin).A medicine for the prevention and / or treatment of arteriosclerosis, hypertension, heart disease, kidney disease or cerebrovascular disease. It comprises the following ingredients as active ingredients: (A) an angiotensin II receptor antagonist selected from the group consisting of a compound represented by the following formula (I), pharmacologically acceptable esters thereof, and pharmacologically acceptable salts thereof (e.g., olmesartan medoxomil); and (B) a calcium antagonist selected from the group consisting of 1,4-dihydropyridine compounds and their pharmacologically acceptable salts (e.g., azelnidipine).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003022990 | 2003-01-31 | ||
| PCT/JP2004/000861 WO2004067003A1 (en) | 2003-01-31 | 2004-01-29 | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20054020D0 NO20054020D0 (en) | 2005-08-30 |
| NO20054020L true NO20054020L (en) | 2005-10-27 |
| NO334451B1 NO334451B1 (en) | 2014-03-03 |
Family
ID=36840895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054020A NO334451B1 (en) | 2003-01-31 | 2005-08-30 | Medication for use in preventing and / or treating hypertension or arteriosclerosis and using the ingredients for the manufacture of a medicament for such use. |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN1809353B (en) |
| NO (1) | NO334451B1 (en) |
| UA (1) | UA82216C2 (en) |
| ZA (1) | ZA200506076B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| US5492904A (en) * | 1991-05-15 | 1996-02-20 | E. I. Du Pont De Nemours And Company | Composition of angiotensin-II receptor antagonists and calcium channel blockers |
-
2004
- 2004-01-29 UA UAA200507589A patent/UA82216C2/en unknown
- 2004-01-29 CN CN200480008667.0A patent/CN1809353B/en not_active Expired - Lifetime
-
2005
- 2005-07-28 ZA ZA200506076A patent/ZA200506076B/en unknown
- 2005-08-30 NO NO20054020A patent/NO334451B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1809353A (en) | 2006-07-26 |
| NO334451B1 (en) | 2014-03-03 |
| UA82216C2 (en) | 2008-03-25 |
| CN1809353B (en) | 2010-05-05 |
| ZA200506076B (en) | 2006-05-31 |
| NO20054020D0 (en) | 2005-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05008142A (en) | Medicine for prevention of and treatment for arteriosclerosis and hypertension. | |
| EP2423207A3 (en) | 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors | |
| NO20060195L (en) | Quinolylamide derivatives as CCR-5 antagonists | |
| NO20053762L (en) | Condensed furan compound. | |
| NO20072978L (en) | New betuene derivatives, their preparation and their use | |
| NO20082265L (en) | Dispersible tablets including deferasirox | |
| NO20054868L (en) | CaSr antagonist | |
| NO20092286L (en) | Nitrogen-containing heterocyclic compounds and their use | |
| NO20072371L (en) | Kinuclidine derivatives and their use as muscarinic M3 receptor antagonists | |
| NO20054220L (en) | Substituted N-aryl heterocycles, process for their preparation and their use as a drug | |
| NO20065060L (en) | Pharmaceutical combinations containing benzoxazine for the treatment of respiratory disorders | |
| NO20032261L (en) | Medical preparations | |
| NO20092033L (en) | New connections | |
| NO20073720L (en) | Heterocyclic substituted phenylmethanones as inhibitors of glycine transporters | |
| WO2008050199A8 (en) | Substituted phenylmethyl bicyclocarboxyamide compounds | |
| NO20050921L (en) | New physiologically active substances | |
| NO20062004L (en) | Prolonged release pharmaceutical compositions include aplindor and derivatives thereof | |
| EA200801909A1 (en) | PYRIDINE COMPOUNDS FOR THE TREATMENT OF DISEASES MEDIATED BY PROSTAGLANDINE | |
| NO20071314L (en) | Peptidic vasopressin receptor agonists | |
| CY1107141T1 (en) | METHOD FOR THE PREPARATION OF 1- (2S, 3S) -2-BENZHYDYR-N- (5-TIT-BUTYL-2-Methoxybenzyl) quinuclidin-3-amine | |
| WO2008059370A3 (en) | Substituted bicyclocarboxyamide compounds | |
| NO20064344L (en) | Caspase Inhibitors and Uses thereof | |
| NO20082077L (en) | Spirocyclic quinazoline derivatives as PDE7 inhibitors | |
| NO20060718L (en) | Substituted thiophones and their use | |
| NO20040881L (en) | Oral antidiabetic agents. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |